10q10k10q10k.net
PHIBRO ANIMAL HEALTH CORP

PHIBRO ANIMAL HEALTH CORPPAHCEarnings & Financial Report

Nasdaq

Phibro Animal Health Corporation is an American animal health and mineral nutrition company. Its products include antibacterials, anticoccidials, anthelmintics, as well as animal nutrition and vaccines for livestock. The company operates through three segments Mineral Nutrition, Performance Materials, and Animal Health, from which most of its revenue is derived. The company operates in the United States, Latin America, Canada, Europe, Middle East, Africa, and Asia-Pacific. It is incorporated ...

PAHC Q2 2026 Key Financial Metrics

Revenue

$373.9M

Gross Profit

$132.7M

Operating Profit

$50.3M

Net Profit

$27.5M

Gross Margin

35.5%

Operating Margin

13.5%

Net Margin

7.3%

YoY Growth

20.9%

EPS

$0.67

Financial Flow

PHIBRO ANIMAL HEALTH CORP Q2 2026 Financial Summary

PHIBRO ANIMAL HEALTH CORP reported revenue of $373.9M for Q2 2026, with a net profit of $27.5M (7.3% margin). Cost of goods sold was $241.3M, operating expenses totaled $82.3M.

Key Financial Metrics

Total Revenue$373.9M
Net Profit$27.5M
Gross Margin35.5%
Operating Margin13.5%
Report PeriodQ2 2026

PHIBRO ANIMAL HEALTH CORP Annual Revenue by Year

PHIBRO ANIMAL HEALTH CORP annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.3B).

YearAnnual Revenue
2025$1.3B
2024$1.0B
2023$977.9M
2022$942.3M

Income Statement

Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Revenue$263.2M$273.2M$260.4M$309.3M$347.8M$378.7M$363.9M$373.9M
YoY Growth7.1%7.1%12.6%23.7%32.1%38.6%39.7%20.9%

Balance Sheet

Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Assets$979.0M$982.2M$966.3M$1.29B$1.32B$1.36B$1.39B$1.41B
Liabilities$708.9M$725.5M$707.8M$1.04B$1.05B$1.08B$1.07B$1.07B
Equity$270.1M$256.6M$258.5M$246.8M$266.0M$285.7M$311.7M$332.4M

Cash Flow

Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
Operating CF$11.4M$28.4M$12.6M$3.1M$43.2M$21.3M$9.3M$19.4M